(Q40867544)

24 September 2017

1 reference

title

Nicotine and endogenous opioids: toward specific pharmacotherapy (English)

1 reference

24 September 2017

0 references

Z Ismail

1

1 reference

24 September 2017

N el-Guebaly

series ordinal

2

1 reference

24 September 2017

language of work or name

English

0 references

publication date

1 February 1998

1 reference

Canadian Journal of Psychiatry

24 September 2017

published in

1 reference

24 September 2017

volume

43

1 reference

24 September 2017

issue

1

1 reference

24 September 2017

page(s)

37-42

1 reference

Psychiatric comorbidity of smoking and nicotine dependence

24 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F070674379804300103

Nicotine, negative affect, and depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674379804300103

How to help psychiatric patients stop smoking.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674379804300103

Prevalence of smoking among psychiatric outpatients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674379804300103

Schizophrenia and substance abuse: prevalence issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674379804300103

Nicotine exposure and tardive dyskinesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674379804300103

The female weight-control smoker: a profile

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674379804300103

Measuring nicotine dependence: a review of the Fagerstrom Tolerance Questionnaire

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674379804300103

The neurobiology of tobacco addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674379804300103

Cigarette Smoking: A Dependence on High-Nicotine Boli

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674379804300103

Drugs of abuse: anatomy, pharmacology and function of reward pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674379804300103

The role of reward pathways in the development of drug dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674379804300103

Nicotine dependence, midbrain dopamine systems and psychiatric disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674379804300103

Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674379804300103

Facilitatory modulation of mesolimbic dopamine neuronal activity by a mu-opioid agonist and nicotine as examined with in vivo microdialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674379804300103

Stimulation of [3H]dopamine release by nicotine in rat nucleus accumbens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674379804300103

Nicotine preferentially stimulates dopamine release in the limbic system of freely moving rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674379804300103

Acute administration of nicotine increases the in vivo extracellular levels of dopamine, 3,4-dihydroxyphenylacetic acid and ascorbic acid preferentially in the nucleus accumbens of the rat: comparison with caudate-putamen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674379804300103

Self-administered nicotine activates the mesolimbic dopamine system through the ventral tegmental area.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674379804300103

Neuroregulators and the reinforcement of smoking: towards a biobehavioral explanation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674379804300103

Neuroendocrine reactivity to nicotine in smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674379804300103

Nicotine-induced alterations in brain regional concentrations of native and cryptic Met- and Leu-enkephalin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674379804300103

Nicotine protects against mu-opioid receptor antagonism by beta-funaltrexamine: evidence for nicotine-induced release of endogenous opioids in brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674379804300103

Neuroanatomical patterns of the mu, delta, and kappa opioid receptors of rat brain as determined by quantitative in vitro autoradiography

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674379804300103

Opioid receptors and their ligands: natural and unnatural

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674379804300103

High and low affinity opioid binding sites: Relationship to mu and delta sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674379804300103

Mu-, delta-, kappa-opioid receptors and their subtypes. A critical review with emphasis on radioligand binding experiments.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674379804300103

Evidence for opioid mechanisms in the behavioral effects of nicotine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674379804300103

Naloxone does not affect cigarette smoking

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674379804300103

Effect of naloxone on cigarette smoking

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674379804300103

Naltrexone, smoking behaviour and cigarette withdrawal.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674379804300103

A double-blind, placebo-controlled pilot study to evaluate the efficacy and safety of oral nalmefene HCl for alcohol dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674379804300103

Synthesis and biological evaluation of 14-alkoxymorphinans. 11. 3-Hydroxycyprodime and analogues: opioid antagonist profile in comparison to cyprodime

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674379804300103

10.1177/070674379804300103

21 January 2018

Identifiers

DOI

1 reference

24 September 2017

1 reference